Tofacitinib, an Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: Year 2 Efficacy and Safety Results From a 24-Month Phase 3 Study
作者
D. van der Heijde,Yoshiya Tanaka,R Fleischmann,Edward Keystone,J.M. Kremer,Cristiano A. F. Zerbini,Mario H. Cardiel,S. Cohen,Peter Nash,Yu Song,Dana Tegzová,Bradley T. Wyman,David Gruben,Birgitta Benda,Gene V. Wallenstein,S. Krishnaswami,Samuel H. Zwillich,John Bradley,Carol A. Connell,Oral Scan investigators